CD274 and neoplasm: Although treatments which engage the immune response like Ad-CEA+N-803 and docetaxel had minimal MC38-CEA anti-tumor effect, each agent synergized with PD-L1 and OX40+4-1BB to augment the anti-tumor outcome.